Botulinum toxin treatment of social anxiety disorder with hyperhidrosis: A placebo-controlled double-blind trial

Journal of Clinical Psychiatry

Volumn 67, Issue 1, 2006, Pages 30-36

  Connor, Kathryn M ^a   Cook, Jonathan L ^a   Davidson, Jonathan R T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; PAROXETINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; HYPERHIDROSIS; INSOMNIA; MALE; NAUSEA; OPEN STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEDATION; SOCIAL PHOBIA; STATISTICAL SIGNIFICANCE; SWEATING; TREATMENT OUTCOME; WORK; XEROSTOMIA;

EID: 32244445597     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v67n0105     Document Type: Article

References (28)

1. Strutton DR, Kowalski JW, Glaser DA, et al. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 2004;51:241-248
2. Moran KT, Brady MP. Surgical management of primary hyperhidrosis. Br J Surg 1991;78:279-283
3. Naver H, Aquilonius SM. The treatment of focal hyperhidrosis with botulinum toxin. Eur J Neurol 1997;4(suppl 2):S75-S78
4. Davidson JRT, Foa EB, Connor KM, et al. Hyperhidrosis in social anxiety disorder. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26:1327-1331
5. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomized, parallel group, double blind, placebo controlled trial. BMJ 2001;323:596-599
6. Heckmann M, Ceballos-Baumann AO, Plewig G. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 2001;344: 488-493
7. Swartling C, Naver H, Lindberg M. Botulinum A toxin improves life quality in severe primary local hyperhidrosis. Eur J Neurol 2001;8: 247-252
8. Baldwin D, Bobes J, Stein DJ, et al. Paroxetine in social phobia/social anxiety disorder. Randomized, double-blind, placebo-controlled study. Br J Psychiatry 1999;175:120-126
9. Stein MB, Liebowitz MR, Lydiard RB, et al. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial. JAMA 1998;280:708-713
10. Liebowitz MR, Stein MB, Tancer M, et al. A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder. J Clin Psychiatry 2002;63:66-74
11. Lepola U, Bergtholdt B, St. Lambert J, et al. Controlled-release paroxetine in the treatment of patients with social anxiety disorder. J Clin Psychiatry 2004;65:222-229
12. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33
13. Connor KM, Davidson JRT, Churchill LE, et al. Psychometric properties of the Social Phobia Inventory (SPIN): new self-rating scale. Br J Psychiatry 2000;176:379-386
14. Teale C, Hann H, Naumann M, et al. Development, validity, and reliability of the Hyperhidrosis Impact Questionnaire (HHIQ) [abstract]. Qual Life Res 2002;11:702
15. Davidson JRT, Miner CM, deVeaugh-Geiss J, et al. The Brief Social Phobia Scale: a psychometric evaluation. Psychol Med 1997;27:161-166
16. Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry 1987;22: 141-173
17. Sheehan DV. The Anxiety Disease. New York, NY: Scribner; 1983
18. Goldstein S. Treatment of social phobia with clonidine. Biol Psychiatry 1987;22:369-372
19. Naumann M, Davidson JRT, Glaser DA. Hyperhidrosis: current understanding, current therapy. Medscape Dermatology: Posted February 28, 2002. Available at: http://www.medscape.com/viewprogram/1540. Accessed September 27, 2004
20. Sato K, Kang WH, Saga K, et al. Biology of sweat glands and their disorders, 1: normal sweat gland function. J Am Acad Dermatol 1989;20:537-563
21. Sato K, Kang WH, Saga K, et al. Biology of sweat glands and their disorders, 2: disorders of sweat gland function. J Am Acad Dermatol 1989;20:713-726
22. Stearns V, Ullmer L, Lopez JF, et al. Hot flushes. Lancet 2002;360: 1851-1861
23. Sheard MH, Aghajanian GK. Neural release of brain serotonin and body temperature [abstract]. Nature 1967;216:495-496
24. 1B receptors for citalopram-induced hypothermia in the rat. Psychopharmacology (Berl) 2001;154:429-434
25. Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol 1999;13:100-109
26. Myers RD. Serotonin and thermoregulation: old and new views. J Physiol (Paris) 1981;77:505-513
27. Tancer ME, Mailman RB, Stein MB, et al. Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia. Anxiety 1994-95;1:216-223
28. Mathew SJ, Coplan JD, Gorman JM. Neurobiological mechanisms of social anxiety disorder. Am J Psychiatry 2001;158:1558-1567